Class II HLA Fipitope Level Mismatch Can Predict Chronic Graft-Versus-Host Disease and Survival Following Haploidentical Transplant Using Post-Transplant Cyclophosphamide

Solomon Scott R.; Aubrey Michael T.; Anobile Cheri; Zhang Xu; Freed Brian M.; Morris Lawrence E.; Holland H. Kent; Solh Melhem; Bashey Asad

首页> 外文期刊>Blood: The Journal of the American Society of Hematology >Class II HLA Fipitope Level Mismatch Can Predict Chronic Graft-Versus-Host Disease and Survival Following Haploidentical Transplant Using Post-Transplant Cyclophosphamide

【24h】

Class II HLA Fipitope Level Mismatch Can Predict Chronic Graft-Versus-Host Disease and Survival Following Haploidentical Transplant Using Post-Transplant Cyclophosphamide

机译：II级HLA浮夸级别错配可以使用移植后环磷酰胺预测寄生术移植后慢性接枝腹膜疾病和存活

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Blood: The Journal of the American Society of Hematology》 |2018年第novaelatreatmentappr期|共3页
作者
Solomon Scott R.; Aubrey Michael T.; Anobile Cheri; Zhang Xu; Freed Brian M.; Morris Lawrence E.; Holland H. Kent; Solh Melhem; Bashey Asad;
展开▼
作者单位

Northside Hosp Blood &

Marrow Transplant Program Atlanta GA USA;

ClinImmune Labs Aurora CO USA;

ClinImmune Labs Aurora CO USA;

Univ Texas Houston Sch Publ Hlth Houston TX USA;

ClinImmune Labs Aurora CO USA;

Northside Hosp Blood &

Marrow Transplant Program Atlanta GA USA;

Northside Hosp Blood &

Marrow Transplant Program Atlanta GA USA;

Northside Hosp Blood &

Marrow Transplant Program Atlanta GA USA;

Northside Hosp Blood &

Marrow Transplant Program Atlanta GA USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类血液及淋巴系疾病;
关键词

相似文献

外文文献
中文文献
专利

1. Class II HLA Fipitope Level Mismatch Can Predict Chronic Graft-Versus-Host Disease and Survival Following Haploidentical Transplant Using Post-Transplant Cyclophosphamide [J] . Solomon Scott R., Aubrey Michael T., Anobile Cheri, Blood: The Journal of the American Society of Hematology . 2018,第NovaelaTreatmentAppr期

机译：II级HLA浮夸级别错配可以使用移植后环磷酰胺预测寄生术移植后慢性接枝腹膜疾病和存活
2. Grade II Acute Graft-versus-Host Disease and Higher Nucleated Cell Graft Dose Improve Progression-Free Survival after HLA-Haploidentical Transplant with Post-Transplant Cyclophosphamide [J] . Shannon R. McCurdy, Christopher G. Kanakry, Hua-Ling Tsai, Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation . 2018,第2期

机译：II级急性移植物 - 宿主病和高核细胞移植剂剂量改善HLA-HA-HAPPLAIDICE移植后的无进展存活后的移植后环磷酰胺
3. The Predicted Indirectly Recognizable HLA Epitopes (PIRCHE) Score for HLA Class I Graft-versus-Host Disparity Is Associated with Increased Acute Graft-versus-Host Disease in Haploidentical Transplantation with Post-Transplantation Cyclophosphamide [J] . Rimando Joseph, Slade Michael, DiPersio John F., Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation . 2020,第1期

机译：HLA类移植物 - 与宿主视差的预测间接可识别的HLA表位（PIRCHE）得分与随移植后环磷酰胺的急性移植物与宿主疾病增加有关
4. Anti-Thymocyte-Globulin (ATG-Fresenius) for Prevention of Acute and Chronic Graft-versus-Host Disease in Pediatric and Adult Recipients of Unrelated Donor Bone Marrow Transplantation [C] . . 2006

机译：抗胸腺细胞球蛋白（ATG-Fresenius）预防无关供体骨髓移植的小儿和成年患者的急性和慢性移植物抗宿主病
5. Symptoms, Cytokines, and Quality of Life of Patients with Chronic Graft-versus-Host Disease following Allogeneic Hematopoietic Stem Cell Transplantation. [D] . Kelly, Debra Lynch. 2014

机译：异基因造血干细胞移植后慢性移植物抗宿主病患者的症状，细胞因子和生活质量。
6. Grade II Acute Graft-versus-Host Disease and Higher Nucleated Cell Graft Dose Improve Progression-Free Survival after HLA-Haploidentical Transplant with Post-Transplant Cyclophosphamide [O] . Shannon R. McCurdy, Christopher G. Kanakry, Hua-Ling Tsai, -1

机译：II级急性移植物抗宿主病和高细胞核移植物剂量提高了HLA单倍体移植后环磷酰胺移植后的无进展生存率
7. The new refined minnesota risk score for acute graft-versus-host disease predicts overall survival and non-relapse mortality after T cell-replete haploidentical stem cell transplant with post-transplant cyclophosphamide [O] . Jacopo Mariotti, Angela Granata, Stefania Bramanti, 2019

机译：急性接枝与宿主病的新精致明尼苏达风险评分预测与移植后环磷酰胺的T细胞 - 填充寄生干细胞移植后的整体存活和非复发性质

Class II HLA Fipitope Level Mismatch Can Predict Chronic Graft-Versus-Host Disease and Survival Following Haploidentical Transplant Using Post-Transplant Cyclophosphamide

著录项

相似文献

相关主题

期刊订阅